Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Donepezil | hsa00030 | Pentose phosphate pathway | 1.08E-05 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Donepezil | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Donepezil | hsa00190 | Oxidative phosphorylation | 5.12E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Donepezil | hsa00220 | Arginine biosynthesis | 2.49E-02 | 1 | P15104 | GLUL | More | | Donepezil | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.92E-02 | 1 | P15104 | GLUL | More | | Donepezil | hsa00260 | Glycine, serine and threonine metabolism | 2.49E-02 | 1 | P22557 | ALAS2 | More | | Donepezil | hsa00310 | Lysine degradation | 1.53E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Donepezil | hsa00500 | Starch and sucrose metabolism | 1.30E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Donepezil | hsa00512 | Mucin type O-glycan biosynthesis | 1.86E-03 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Donepezil | hsa00514 | Other types of O-glycan biosynthesis | 3.20E-02 | 2 | O15294, Q9NY28 | OGT, GALNT8 | More | | Donepezil | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | | Donepezil | hsa00562 | Inositol phosphate metabolism | 2.54E-03 | 4 | P27987, Q13572, Q96PE3, P42338 | ITPKB, ITPK1, INPP4A, PIK3CB | More | | Donepezil | hsa00565 | Ether lipid metabolism | 4.92E-02 | 1 | Q8N661 | TMEM86B | More | | Donepezil | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Donepezil | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Donepezil | hsa00730 | Thiamine metabolism | 1.29E-05 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Donepezil | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | | Donepezil | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Donepezil | hsa00830 | Retinol metabolism | 3.49E-02 | 1 | P00325 | ADH1B | More | | Donepezil | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Donepezil | hsa00910 | Nitrogen metabolism | 2.49E-02 | 1 | P15104 | GLUL | More | | Donepezil | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Donepezil | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6.67E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Donepezil | hsa00982 | Drug metabolism - cytochrome P450 | 6.67E-04 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Donepezil | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Donepezil | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Donepezil | hsa01230 | Biosynthesis of amino acids | 2.22E-03 | 4 | P51854, P60891, Q99707, P37837 | TKTL1, PRPS1, MTR, TALDO1 | More | | Donepezil | hsa01522 | Endocrine resistance | 4.55E-02 | 5 | P14780, P22694, Q9UM47, P10415, Q13323 | MMP9, PRKACB, NOTCH3, BCL2, BIK | More | | Donepezil | hsa01524 | Platinum drug resistance | 3.62E-02 | 4 | Q13489, P98170, P78417, P43246 | BIRC3, BIRC4, GSTO1, MSH2 | More | | Donepezil | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Donepezil | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Donepezil | hsa03013 | RNA transport | 2.35E-05 | 10 | O14980, P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, Q14240, P23588, Q9Y6A5 | XPO1, NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF4A2, EIF4B, TACC3 | More | | Donepezil | hsa03015 | mRNA surveillance pathway | 2.95E-02 | 3 | O94913, Q9H307, Q13148 | PCF11, PNN, TARDBP | More | | Donepezil | hsa03020 | RNA polymerase | 5.24E-06 | 4 | P24928, P62487, Q9GZM3, P52435 | POLR2A, POLR2G, POLR2J2, POLR2J | More | | Donepezil | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Donepezil | hsa03040 | Spliceosome | 2.05E-08 | 14 | Q14562, O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.745 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.734 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.859 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.784 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.714 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.747 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.774 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.793 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Donepezil | hsa03050 | Proteasome | 2.26E-02 | 2 | P55036, P28074 | PSMD4, PSMB5 | More | | Donepezil | hsa03060 | Protein export | 3.56E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Donepezil | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | | Donepezil | hsa03410 | Base excision repair | 7.59E-03 | 1 | P27695 | APEX1 | More | | Donepezil | hsa04014 | Ras signaling pathway | 7.16E-05 | 13 | P42338, P20827, P49767, Q13009, Q15311, Q7LDG7, Q14644, P0DP23, P62873, P63218, P50151, P19174, P17612 | PIK3CB, EFNA1, VEGFC, TIAM1, RALBP1, RASGRP2, RASA3, CALM1, GNB1, GNG5, GNG10, PLCG1, PRKACA | More | | Donepezil | hsa04015 | Rap1 signaling pathway | 1.79E-02 | 8 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Donepezil | hsa04020 | Calcium signaling pathway | 1.26E-07 | 15 | P27987, Q08828, P21796, Q16566, Q13557, P30679, O15399, P61073, P0DP24, P0DP23, P05141, P51828, P07550, P23634, P49767 | ITPKB, ADCY1, VDAC1, CAMK4, CAMK2D, GNA15, GRIN2D, CXCR4, CALM2, CALM1, SLC25A5, ADCY7, ADRB2, ATP2B4, VEGFC | More | | Donepezil | hsa04022 | cGMP-PKG signaling pathway | 1.44E-03 | 7 | Q99941, P18848, Q8WYR1, Q08828, P51828, P05141, P0DP24 | CREBL1, ATF4, PIK3R5, ADCY1, ADCY7, SLC25A5, CALM2 | More | | Donepezil | hsa04024 | cAMP signaling pathway | 1.49E-02 | 5 | P42338, P0DP23, P23634, Q16566, O15399 | PIK3CB, CALM1, ATP2B4, CAMK4, GRIN2D | More | | Donepezil | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.67E-03 | 8 | Q8NHW4, P09341, P19875, P25024, P25025, P61073, Q13651, P14784 | CCL4L2, CXCL1, CXCL2, CXCR1, CXCR2, CXCR4, IL10RA, IL2RB | More | | Donepezil | hsa04062 | Chemokine signaling pathway | 8.18E-05 | 14 | P25024, P25025, P09341, P19875, P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Donepezil | hsa04064 | NF-kappa B signaling pathway | 2.62E-06 | 22 | Q07817, P10415, Q13489, P51617, O00463, P14778, P01584, P01375, P19174, Q04759, Q9UDY8, Q13077, P19784, Q16548, P06239, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2L1, BCL2, BIRC3, IRAK1, TRAF5, IL1R1, IL1B, TNF, PLCG1, PRKCQ, MALT1, TRAF1, CSNK2A2, BCL2A1, LCK, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | | Donepezil | hsa04070 | Phosphatidylinositol signaling system | 1.49E-03 | 5 | P0DP23, P42338, Q96PE3, Q13572, P27987 | CALM1, PIK3CB, INPP4A, ITPK1, ITPKB | More | | Donepezil | hsa04071 | Sphingolipid signaling pathway | 4.61E-06 | 9 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Donepezil | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Donepezil | hsa04080 | Neuroactive ligand-receptor interaction | 3.82E-03 | 10 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21462, P21730, Q16581, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, C3AR1, ADRB2 | More | | Donepezil | hsa04114 | Oocyte meiosis | 3.72E-06 | 13 | Q9Y6D9, P51812, Q02750, Q13557, P0DP24, P0DP23, P16298, Q17RY0, P17612, Q08828, P51828, P27348, Q13362 | MAD1L1, RPS6KA3, MAP2K1, CAMK2D, CALM2, CALM1, PPP3CB, CPEB4, PRKACA, ADCY1, ADCY7, YWHAQ, PPP2R5C | More | | Donepezil | hsa04120 | Ubiquitin mediated proteolysis | 3.75E-04 | 8 | Q14145, Q13042, P30260, Q13191, P62837, Q15751, O95071, P0CG47 | KEAP1, CDC16, CDC27, CBLB, UBE2D2, HERC1, UBR5, UBB | More | | Donepezil | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Donepezil | hsa04137 | Mitophagy - animal | 6.50E-04 | 3 | P19784, Q07817, P0CG47 | CSNK2A2, BCL2L1, UBB | More | | Donepezil | hsa04140 | Autophagy - animal | 4.55E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Donepezil | hsa04144 | Endocytosis | 4.07E-03 | 5 | Q9H444, O75351, P42566, Q15438, Q14161 | CHMP4B, VPS4B, EPS15, PSCD1, GIT2 | More | | Donepezil | hsa04145 | Phagosome | 1.08E-02 | 8 | O75015, Q15080, P14598, Q13509, P05164, O60603, P35443, P13765 | FCGR3B, NCF4, NCF1, TUBB3, MPO, TLR2, THBS4, HLA-DOB | More | | Donepezil | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Donepezil | hsa04151 | PI3K-Akt signaling pathway | 1.67E-03 | 18 | P62753, P42338, P43657, O43521, P27348, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P18848, O00141, Q6ZUJ8, P30281 | RPS6, PIK3CB, P2RY5, BCL2L11, YWHAQ, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, ATF4, SGK, PIK3AP1, CCND3 | More | | Donepezil | hsa04210 | Apoptosis | 4.66E-03 | 7 | O76075, P01375, Q9NR28, O75460, Q16548, O43521, P18848 | DFFB, TNF, DIABLO, ERN1, BCL2A1, BCL2L11, ATF4 | More | | Donepezil | hsa04211 | Longevity regulating pathway | 4.98E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Donepezil | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Donepezil | hsa04217 | Necroptosis | 2.85E-09 | 21 | P01375, P01568, P23458, P48023, Q13489, Q9NQC7, P42224, Q14765, P08238, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, Q93077, Q13557, Q9H444, O43633, O75351, Q08752 | TNF, IFNA21, JAK1, FASLG, BIRC3, CYLD, STAT1, STAT4, HSP90AB1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, HIST1H2AC, CAMK2D, CHMP4B, CHMP2A, VPS4B, PPID | More | | Donepezil | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.08E-04 | 11 | P07550, Q08828, P51828, P17612, P22694, Q99941, P18848, Q13362, P0DP24, P0DP23, Q13557 | ADRB2, ADCY1, ADCY7, PRKACA, PRKACB, CREBL1, ATF4, PPP2R5C, CALM2, CALM1, CAMK2D | More | | Donepezil | hsa04340 | Hedgehog signaling pathway | 4.15E-03 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Donepezil | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Donepezil | hsa04370 | VEGF signaling pathway | 1.79E-05 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Donepezil | hsa04371 | Apelin signaling pathway | 8.38E-06 | 10 | P62873, P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Donepezil | hsa04380 | Osteoclast differentiation | 4.98E-02 | 4 | Q9NQC7, Q9UQC2, P23458, P01584 | CYLD, GAB2, JAK1, IL1B | More | | Donepezil | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Donepezil | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 4.73E-02 | 3 | Q13873, Q02750, Q86SE9 | BMPR2, MAP2K1, PCGF5 | More | | Donepezil | hsa04612 | Antigen processing and presentation | 1.41E-05 | 9 | P13765, P48382, Q14953, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Donepezil | hsa04613 | Neutrophil extracellular trap formation | 1.40E-06 | 23 | P17252, O60603, P05164, P08246, Q9UM07, Q13547, Q92769, P04908, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P22894 | MMP8 | Neutrophil collagenase | P17252 | PRKCA | Protein kinase C alpha type | -0.759 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P22894 | MMP8 | Neutrophil collagenase | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.867 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | P22894 | MMP8 | Neutrophil collagenase | P05164 | MPO | Myeloperoxidase | 0.905 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P05164 | MPO | Myeloperoxidase | 0.711 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | P22894 | MMP8 | Neutrophil collagenase | P08246 | ELA2 | Neutrophil elastase | 0.985 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.703 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.9 | P22894 | MMP8 | Neutrophil collagenase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.877 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.825 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.742 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q92769 | HDAC2 | Histone deacetylase 2 | -0.746 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.74 | P22894 | MMP8 | Neutrophil collagenase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.909 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P22894 | MMP8 | Neutrophil collagenase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.74 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.869 | P22894 | MMP8 | Neutrophil collagenase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.963 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.764 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20160 | AZU1 | Azurocidin | 0.734 | P22894 | MMP8 | Neutrophil collagenase | P20160 | AZU1 | Azurocidin | 0.824 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08311 | CTSG | Cathepsin G | 0.79 | P22894 | MMP8 | Neutrophil collagenase | P08311 | CTSG | Cathepsin G | 0.8 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P08311 | CTSG | Cathepsin G | 0.709 | P22894 | MMP8 | Neutrophil collagenase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.7 | P14780 | MMP9 | Matrix metalloproteinase-9 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.928 | P22894 | MMP8 | Neutrophil collagenase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.734 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.893 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.942 | P22894 | MMP8 | Neutrophil collagenase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.756 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.912 | P22894 | MMP8 | Neutrophil collagenase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.88 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.842 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P14780 | MMP9 | Matrix metalloproteinase-9 | O43315 | AQP9 | Aquaporin-9 | 0.837 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O43315 | AQP9 | Aquaporin-9 | 0.915 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 |
| Donepezil | hsa04621 | NOD-like receptor signaling pathway | 2.62E-02 | 11 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CXCL1, DEFA4 | More | | Donepezil | hsa04623 | Cytosolic DNA-sensing pathway | 6.43E-04 | 4 | P01584, P01568, P25963, Q8NHW4 | IL1B, IFNA21, NFKBIA, CCL4L2 | More | | Donepezil | hsa04625 | C-type lectin receptor signaling pathway | 4.80E-02 | 6 | Q9ULY5, P20749, Q14643, P01375, Q13191, Q16539 | CLEC4E, BCL3, ITPR1, TNF, CBLB, MAPK14 | More | | Donepezil | hsa04640 | Hematopoietic cell lineage | 1.19E-03 | 13 | P13612, P14778, P27930, P11215, P15144, P11836, P25063, P07766, P09693, P01732, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF | More | | Donepezil | hsa04650 | Natural killer cell mediated cytotoxicity | 3.88E-09 | 17 | P16298, P50591, P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q02750, Q13241, P26718, O14931, O75015, P26717, Q14953, P26715 | PPP3CB, TNFSF10, PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q05397 | PTK2 | Focal adhesion kinase 1 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.919 | P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | Q05397 | PTK2 | Focal adhesion kinase 1 | P50591 | TNFSF10 | Tumor necrosis factor ligand superfamily member 10 | 0.849 | P11511 | CYP19A1 | Aromatase | P50591 | TNFSF10 | Tumor necrosis factor ligand superfamily member 10 | 0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.809 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.81 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.77 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.727 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.898 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.856 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.838 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.879 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.893 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.838 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.72 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q14953 | KIR2DS5 | Killer cell immunoglobulin-like receptor 2DS5 | 0.815 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.838 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.72 |
| Donepezil | hsa04657 | IL-17 signaling pathway | 6.47E-06 | 12 | P08238, O00463, Q07955, Q16539, P49841, P09341, P19875, P14780, Q9UJX4, P04141, P80188, P01375 | HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL1, CXCL2, MMP9, ANAPC5, CSF2, LCN2, TNF | More | | Donepezil | hsa04658 | Th1 and Th2 cell differentiation | 4.28E-07 | 13 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Donepezil | hsa04659 | Th17 cell differentiation | 1.31E-05 | 15 | Q04759, Q16539, P19174, P06239, P14784, P13765, P14778, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | | Donepezil | hsa04660 | T cell receptor signaling pathway | 1.56E-06 | 15 | P01375, Q9UDY8, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.767 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q04759 | PRKCQ | Protein kinase C theta type | -0.762 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P14780 | MMP9 | Matrix metalloproteinase-9 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.792 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.806 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.812 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.77 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.816 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.793 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.816 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 | P14780 | MMP9 | Matrix metalloproteinase-9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.75 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.781 |
| Donepezil | hsa04662 | B cell receptor signaling pathway | 8.11E-05 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Donepezil | hsa04664 | Fc epsilon RI signaling pathway | 7.71E-05 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Donepezil | hsa04666 | Fc gamma R-mediated phagocytosis | 3.62E-03 | 8 | O75015, P07948, P42338, P23528, P06396, O14494, P14598, P17252 | FCGR3B, LYN, PIK3CB, CFL1, GSN, PLPP1, NCF1, PRKCA | More | | Donepezil | hsa04668 | TNF signaling pathway | 2.67E-03 | 6 | P01375, P18848, P19875, P01584, P14780, P20333 | TNF, ATF4, CXCL2, IL1B, MMP9, TNFRSF1B | More | | Donepezil | hsa04713 | Circadian entrainment | 5.83E-05 | 9 | O15399, P0DP24, P0DP23, Q13557, P63218, P50151, Q08828, P51828, P17612 | GRIN2D, CALM2, CALM1, CAMK2D, GNG5, GNG10, ADCY1, ADCY7, PRKACA | More | | Donepezil | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Donepezil | hsa04720 | Long-term potentiation | 3.99E-07 | 11 | Q16566, Q13557, P16298, P0DP24, P0DP23, P51812, P18848, O15399, P17612, Q08828, Q02750 | CAMK4, CAMK2D, PPP3CB, CALM2, CALM1, RPS6KA3, ATF4, GRIN2D, PRKACA, ADCY1, MAP2K1 | More | | Donepezil | hsa04721 | Synaptic vesicle cycle | 3.15E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Donepezil | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Donepezil | hsa04724 | Glutamatergic synapse | 4.51E-04 | 5 | O15399, P43003, P63218, P50151, P15104 | GRIN2D, SLC1A3, GNG5, GNG10, GLUL | More | | Donepezil | hsa04725 | Cholinergic synapse | 4.70E-05 | 8 | Q08828, P51828, P63218, P50151, P18848, Q16566, Q13557, P42338 | ADCY1, ADCY7, GNG5, GNG10, ATF4, CAMK4, CAMK2D, PIK3CB | More | | Donepezil | hsa04726 | Serotonergic synapse | 1.52E-02 | 4 | P63218, P50151, P33260, P09917 | GNG5, GNG10, CYP2C18, ALOX5 | More | | Donepezil | hsa04727 | GABAergic synapse | 1.14E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Donepezil | hsa04728 | Dopaminergic synapse | 2.26E-04 | 11 | P17612, P63218, P50151, Q99941, P18848, Q13557, Q13362, P0DP24, P0DP23, O15516, O00327 | PRKACA, GNG5, GNG10, CREBL1, ATF4, CAMK2D, PPP2R5C, CALM2, CALM1, CLOCK, ARNTL | More | | Donepezil | hsa04740 | Olfactory transduction | 4.53E-04 | 3 | Q9H255, P0DP23, P17612 | OR51E2, CALM1, PRKACA | More | | Donepezil | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Donepezil | hsa04744 | Phototransduction | 5.92E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Donepezil | hsa04750 | Inflammatory mediator regulation of TRP channels | 8.76E-05 | 10 | P14778, P01584, Q08828, P51828, Q13557, P19174, P42338, P24723, Q04759, P0DP24 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM2 | More | | Donepezil | hsa04910 | Insulin signaling pathway | 1.91E-03 | 5 | P0DP23, P17612, P22694, P06737, P49841 | CALM1, PRKACA, PRKACB, PYGL, GSK3B | More | | Donepezil | hsa04911 | Insulin secretion | 7.16E-04 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Donepezil | hsa04912 | GnRH signaling pathway | 1.60E-03 | 9 | Q08828, P51828, P18848, Q13557, Q16539, Q9Y6R4, Q14643, P0DP24, P22694 | ADCY1, ADCY7, ATF4, CAMK2D, MAPK14, MAP3K4, ITPR1, CALM2, PRKACB | More | | Donepezil | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Donepezil | hsa04914 | Progesterone-mediated oocyte maturation | 7.22E-04 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | | Donepezil | hsa04916 | Melanogenesis | 6.31E-04 | 6 | P17612, Q13557, P0DP24, P0DP23, Q08828, P51828 | PRKACA, CAMK2D, CALM2, CALM1, ADCY1, ADCY7 | More | | Donepezil | hsa04918 | Thyroid hormone synthesis | 4.47E-03 | 5 | Q08828, P51828, Q99941, P18848, P02768 | ADCY1, ADCY7, CREBL1, ATF4, ALB | More | | Donepezil | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Donepezil | hsa04920 | Adipocytokine signaling pathway | 4.72E-02 | 4 | P33121, Q04759, Q9Y4H2, P01375 | ACSL1, PRKCQ, IRS2, TNF | More | | Donepezil | hsa04921 | Oxytocin signaling pathway | 1.84E-02 | 3 | P0DP23, P17612, Q96RR4 | CALM1, PRKACA, CAMKK2 | More | | Donepezil | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Donepezil | hsa04924 | Renin secretion | 1.22E-03 | 4 | P17612, P22694, P07550, P0DP23 | PRKACA, PRKACB, ADRB2, CALM1 | More | | Donepezil | hsa04925 | Aldosterone synthesis and secretion | 4.09E-05 | 9 | Q99941, P18848, Q08828, P51828, P0DP24, P0DP23, Q16566, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CALM1, CAMK4, CAMK2D, ATP2B4 | More | | Donepezil | hsa04926 | Relaxin signaling pathway | 3.93E-04 | 8 | P42338, P63218, P50151, P18848, P22694, P49767, P14780, P30679 | PIK3CB, GNG5, GNG10, ATF4, PRKACB, VEGFC, MMP9, GNA15 | More | | Donepezil | hsa04927 | Cortisol synthesis and secretion | 1.43E-04 | 5 | Q99941, P18848, Q08828, P51828, P22694 | CREBL1, ATF4, ADCY1, ADCY7, PRKACB | More | | Donepezil | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.77E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Donepezil | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Donepezil | hsa04932 | Non-alcoholic fatty liver disease | 1.91E-06 | 12 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, P12074, O15239, Q16718, O14521 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFA5, SDHD | More | | Donepezil | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.22E-03 | 6 | P84022, Q13485, P42338, Q12778, P49767, P19174 | SMAD3, SMAD4, PIK3CB, FOXO1, VEGFC, PLCG1 | More | | Donepezil | hsa04934 | Cushing syndrome | 2.60E-04 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | | Donepezil | hsa04935 | Growth hormone synthesis, secretion and action | 4.98E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Donepezil | hsa04940 | Type I diabetes mellitus | 2.61E-03 | 4 | P10747, P48023, P13765, P01375 | CD28, FASLG, HLA-DOB, TNF | More | | Donepezil | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | | Donepezil | hsa04970 | Salivary secretion | 1.19E-04 | 8 | P07550, Q08828, P51828, P17612, P22694, P0DP24, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACA, PRKACB, CALM2, CALM1, CAMP | More | | Donepezil | hsa04971 | Gastric acid secretion | 6.68E-05 | 7 | Q08828, P51828, P17612, P15311, P0DP24, P0DP23, Q13557 | ADCY1, ADCY7, PRKACA, VIL2, CALM2, CALM1, CAMK2D | More | | Donepezil | hsa04973 | Carbohydrate digestion and absorption | 6.19E-05 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Donepezil | hsa04976 | Bile secretion | 9.87E-05 | 5 | O43315, P17612, P22694, P08183, Q14032 | AQP9, PRKACA, PRKACB, ABCB1, BAAT | More | | Donepezil | hsa05010 | Alzheimer disease | 3.52E-04 | 12 | O15239, P13073, P12074, Q00535, O75460, P0DP24, P01584, P18848, O15169, P05141, P28070, P43686 | NDUFA1, COX4I1, COX6A1, CDK5, ERN1, CALM2, IL1B, ATF4, AXIN1, SLC25A5, PSMB4, PSMC4 | More | | Donepezil | hsa05012 | Parkinson disease | 9.66E-04 | 10 | O15239, P13073, P12074, P05141, O75460, P18848, P28070, P43686, P0DP24, Q13557 | NDUFA1, COX4I1, COX6A1, SLC25A5, ERN1, ATF4, PSMB4, PSMC4, CALM2, CAMK2D | More | | Donepezil | hsa05016 | Huntington disease | 2.79E-05 | 12 | O15239, P13073, P12074, Q9GZM3, P24928, P62487, P52435, P05141, Q9NYC9, O75460, P28070, P43686 | NDUFA1, COX4I1, COX6A1, POLR2J2, POLR2A, POLR2G, POLR2J, SLC25A5, DNAH9, ERN1, PSMB4, PSMC4 | More | | Donepezil | hsa05017 | Spinocerebellar ataxia | 3.86E-03 | 5 | Q8TB72, O15399, P42338, P28074, P21796 | PUM2, GRIN2D, PIK3CB, PSMB5, VDAC1 | More | | Donepezil | hsa05020 | Prion disease | 1.42E-03 | 13 | P01584, P46531, O15239, Q16718, O14521, P12074, P18848, P05141, P28070, P43686, P49841, Q99941, Q16539 | IL1B, NOTCH1, NDUFA1, NDUFA5, SDHD, COX6A1, ATF4, SLC25A5, PSMB4, PSMC4, GSK3B, CREBL1, MAPK14 | More | | Donepezil | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.95E-06 | 21 | P49841, O15239, Q16718, O14521, P13073, P12074, Q8TEV9, O75460, P18848, Q13561, P05141, P20333, Q16539, Q00535, O15169, P01584, Q08752, P0DP24, Q13557, P28070, P43686 | GSK3B, NDUFA1, NDUFA5, SDHD, COX4I1, COX6A1, SMCR8, ERN1, ATF4, DCTN2, SLC25A5, TNFRSF1B, MAPK14, CDK5, AXIN1, IL1B, PPID, CALM2, CAMK2D, PSMB4, PSMC4 | More | | Donepezil | hsa05030 | Cocaine addiction | 3.54E-02 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Donepezil | hsa05031 | Amphetamine addiction | 8.86E-05 | 8 | P0DP24, P0DP23, Q13557, P17612, P22694, Q99941, P18848, Q13547 | CALM2, CALM1, CAMK2D, PRKACA, PRKACB, CREBL1, ATF4, HDAC1 | More | | Donepezil | hsa05033 | Nicotine addiction | 1.22E-02 | 2 | P28472, O15399 | GABRB3, GRIN2D | More | | Donepezil | hsa05034 | Alcoholism | 3.35E-06 | 12 | O15399, P17612, Q16566, P0DP23, Q96RR4, P62873, P63218, P50151, Q93077, P62807, O60814, P68431 | GRIN2D, PRKACA, CAMK4, CALM1, CAMKK2, GNB1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Donepezil | hsa05100 | Bacterial invasion of epithelial cells | 1.82E-03 | 4 | Q14141, Q05397, Q92529, Q96JJ3 | SEPT6, PTK2, SHC3, ELMO2 | More | | Donepezil | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Donepezil | hsa05133 | Pertussis | 1.88E-02 | 3 | P11215, P0DP23, P23528 | ITGAM, CALM1, CFL1 | More | | Donepezil | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Donepezil | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | | Donepezil | hsa05140 | Leishmaniasis | 1.18E-06 | 12 | P13612, O75015, P14598, P42224, P13765, O60603, P25963, P01375, P29350, Q16539, P51617, Q15080 | ITGA4, FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MAPK14, IRAK1, NCF4 | More | | Donepezil | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Donepezil | hsa05144 | Malaria | 9.55E-04 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Donepezil | hsa05146 | Amoebiasis | 1.70E-08 | 14 | Q13751, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P30679, P22694, P12814, P08311 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | | Donepezil | hsa05150 | Staphylococcus aureus infection | 1.65E-02 | 6 | P21730, P21462, O75015, P13765, Q16581, P49913 | C5AR1, FPR1, FCGR3B, HLA-DOB, C3AR1, CAMP | More | | Donepezil | hsa05152 | Tuberculosis | 8.54E-03 | 9 | O75015, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617 | FCGR3B, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | | Donepezil | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Donepezil | hsa05163 | Human cytomegalovirus infection | 3.01E-05 | 15 | P42338, P63218, P50151, P0DP24, P0DP23, Q8NHW4, Q08828, P51828, P23458, P01584, P61073, Q13651, Q99941, P18848, P30101 | PIK3CB, GNG5, GNG10, CALM2, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, CXCR4, IL10RA, CREBL1, ATF4, PDIA3 | More | | Donepezil | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.44E-03 | 9 | P42338, P62879, P63218, P50151, P16298, Q02750, P07948, P0DP23, P0CG47 | PIK3CB, GNB2, GNG5, GNG10, PPP3CB, MAP2K1, LYN, CALM1, UBB | More | | Donepezil | hsa05168 | Herpes simplex virus 1 infection | 3.38E-03 | 12 | P25963, P01568, Q05823, P42224, Q07955, Q13243, Q13489, Q13398, Q9HCX3, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS5, BIRC3, ZNF211, ZNF304, ZNF140, ZNF189, ZNF212 | More | | Donepezil | hsa05170 | Human immunodeficiency virus 1 infection | 7.38E-04 | 11 | P42338, Q02750, P62879, P63218, P50151, P16298, P0DP23, Q05397, P30101, P23528, P20333 | PIK3CB, MAP2K1, GNB2, GNG5, GNG10, PPP3CB, CALM1, PTK2, PDIA3, CFL1, TNFRSF1B | More | | Donepezil | hsa05200 | Pathways in cancer | 2.54E-04 | 23 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, Q13489, P98170, P49767, Q12778, P43657, P62873, P63218, P50151, Q14344, Q7LDG7, P78417, O75293, P0DP23, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, BIRC3, BIRC4, VEGFC, FOXO1, P2RY5, GNB1, GNG5, GNG10, GNA13, RASGRP2, GSTO1, GADD45B, CALM1, IL2RB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.732 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.736 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.708 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.749 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.741 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | -0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.811 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | Q12778 | FOXO1 | Forkhead box protein O1 | -0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.767 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.913 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P0DP23 | CALM1 | Calmodulin-1 | 0.739 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 |
| Donepezil | hsa05202 | Transcriptional misregulation in cancer | 2.75E-05 | 20 | Q12778, Q15532, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | FOXO1, SS18, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P22894 | MMP8 | Neutrophil collagenase | Q12778 | FOXO1 | Forkhead box protein O1 | -0.72 | P22894 | MMP8 | Neutrophil collagenase | Q15532 | SS18 | Protein SSXT | -0.867 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P41732 | TSPAN7 | Tetraspanin-7 | 0.703 | P14780 | MMP9 | Matrix metalloproteinase-9 | P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | P22894 | MMP8 | Neutrophil collagenase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.882 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.942 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.924 | P22894 | MMP8 | Neutrophil collagenase | P14923 | JUP | Junction plakoglobin | -0.809 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.7 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.921 | P22894 | MMP8 | Neutrophil collagenase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.843 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.913 | P22894 | MMP8 | Neutrophil collagenase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.765 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.758 | P22894 | MMP8 | Neutrophil collagenase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.806 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.712 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | P22894 | MMP8 | Neutrophil collagenase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.821 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | P22894 | MMP8 | Neutrophil collagenase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.821 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | P22894 | MMP8 | Neutrophil collagenase | P05164 | MPO | Myeloperoxidase | 0.905 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P05164 | MPO | Myeloperoxidase | 0.711 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.767 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | P22894 | MMP8 | Neutrophil collagenase | P08246 | ELA2 | Neutrophil elastase | 0.985 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.703 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.752 | P22894 | MMP8 | Neutrophil collagenase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.778 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.765 | P14780 | MMP9 | Matrix metalloproteinase-9 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.812 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.9 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.742 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q92769 | HDAC2 | Histone deacetylase 2 | -0.746 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12980 | LYL1 | Protein lyl-1 | 0.716 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P12980 | LYL1 | Protein lyl-1 | 0.782 | P14780 | MMP9 | Matrix metalloproteinase-9 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.765 | P22894 | MMP8 | Neutrophil collagenase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.766 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.801 |
| Donepezil | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Donepezil | hsa05204 | Chemical carcinogenesis | 1.61E-03 | 3 | P78417, P11712, P33260 | GSTO1, CYP2C9, CYP2C18 | More | | Donepezil | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Donepezil | hsa05212 | Pancreatic cancer | 4.21E-03 | 6 | P42338, Q15311, P23458, P84022, Q13485, O75293 | PIK3CB, RALBP1, JAK1, SMAD3, SMAD4, GADD45B | More | | Donepezil | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Donepezil | hsa05214 | Glioma | 2.32E-02 | 3 | P0DP23, Q16566, P42338 | CALM1, CAMK4, PIK3CB | More | | Donepezil | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Donepezil | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | | Donepezil | hsa05231 | Choline metabolism in cancer | 2.23E-02 | 3 | P42338, O15245, Q9Y259 | PIK3CB, SLC22A1, CHKB | More | | Donepezil | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Donepezil | hsa05310 | Asthma | 9.08E-04 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Donepezil | hsa05321 | Inflammatory bowel disease | 5.07E-08 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Donepezil | hsa05322 | Systemic lupus erythematosus | 1.24E-04 | 13 | O75015, P08246, P08311, P09871, P01375, P10747, P13765, Q6FI13, Q93077, P62807, O60814, P68431, P05455 | FCGR3B, ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, SSB | More | | Donepezil | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Donepezil | hsa05332 | Graft-versus-host disease | 7.03E-07 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Donepezil | hsa05415 | Diabetic cardiomyopathy | 4.54E-04 | 8 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P49841, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, GSK3B, GAPDH | More | | Donepezil | hsa05418 | Fluid shear stress and atherosclerosis | 3.50E-02 | 4 | P42338, P10599, P14778, P27930 | PIK3CB, TXN, IL1R1, IL1R2 | More | | |